Bile Duct Cancer Research from Dana-Farber Cancer Institute
3 Views
administrator
06/16/23
New treatment options are greatly needed in Bile Duct Cancer (cholangiocarcinoma). New research led by Dana-Farber's James Cleary, MD, PhD in Cancer Discovery finds FGFR2 deletion may predict clinical benefit to molecularly targeted therapy. Video published April 30, 2021.
-
Category
Show more
Facebook Comments
No comments found